ClinicalTrials.gov
public full text
Public Domain
Efficacy and Safety of AC102 Compared to Steroids in Adults With Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)
The purpose of this Phase 2 clinical trial is to evaluate the safety, tolerability and efficacy of AC102 administered as single intratympanic injection compared to oral steroid treatment in patients with Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment#865457
- 7 U.S.C. § 6998 — Director review of determinations of hearing officers#560240
- Safety Evaluation of SS-POR11#1008239
- Long-Term Follow-up of Adult With Atorpphic Scars Treated With TRTP-101#912710
- A Study to Assess the Safety and Efficacy of Different AD 237 Doses in Adults With COPD#844866
Record · ID 879450
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive